News

Everyday Health on MSN4h
FDA Approves New Preventive Drug for Hereditary Angioedema (HAE)
The antibody-based drug Andembry is the first to target factor XIIa, a protein responsible for swelling in people with this ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
MPR8h
FDA Approves Andembry for Prophylactic Use in Hereditary Angioedema
The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric pa ...
Fierce Pharma9h
With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro
With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s ...
WebMD3d
Hypertension/High Blood Pressure Resource Center
Could Blood Pressure Medication Increase Your Wet AMD Risk? Could the medication you take for hypertension be affecting your vision? Explore the potential link between blood pressure medicine and ...
Ophthalmology Advisor1d
Switch to Faricimab Improves Eyes With Challenging Diabetic Macular Edema
Patients with challenging diabetic macular edema may achieve anatomical gains and extended dosing intervals with bispecific faricimab.